Circassia Group Share Forecast, Price & News

GBX 30.25
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Today's Range
Now: GBX 30.25
50-Day Range
MA: GBX 27.78
52-Week Range
Now: GBX 30.25
Volume254,318 shs
Average Volume829,045 shs
Market Capitalization£126.34 million
P/E RatioN/A
Dividend YieldN/A
Circassia Group Plc, a specialty pharmaceutical company, focuses on the development and commercialization of respiratory products. It operates through three segments: NIOX, Chronic Obstructive Pulmonary Disease (COPD), and LungFit. The company markets NIOX and NIOX VERO for use in asthma diagnosis and management; Tudorza for the treatment of COPD; and Duaklir, a fixed-dose combination of the long-acting muscarinic antagonist aclidinium bromide and long-acting beta agonist formoterol fumarate, which is administered twice-daily through the breath actuated Pressair inhaler for the maintenance treatment of COPD. It is also developing LungFit, a portable ventilator-compatible system that utilizes an electric voltage to produce precise quantities of nitric oxide from the nitrogen and oxygen in air. The company markets its products directly to specialists in the United States, the United Kingdom, China, Italy, and Germany, as well as through a network of partners internationally. Circassia Group Plc has a collaboration agreement with AstraZeneca to promote Tudorza and Duaklir for COPD treatment; and the United States and Chinese commercial rights to LungFit. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was founded in 2006 and is headquartered in Oxford, the United Kingdom.
Circassia Group logo

Industry, Sector and Symbol

Industry Biotechnology
Phone44 1865 405 560
Year FoundedN/A



Sales & Book Value

Annual Sales£23.90 million
Cash FlowGBX 1.98 per share
Book ValueGBX 16.60 per share



Market Cap£126.34 million
Next Earnings Date6/14/2021 (Estimated)


Circassia Group Plc (82C.F)
March 17, 2021 |  ca.finance.yahoo.com
How Much Of Circassia Group Plc (LON:CIR) Do Insiders Own?
February 4, 2021 |  finance.yahoo.com
Circassia Group PLC
December 31, 2020 |  barrons.com
Circassia upbeat on prospects once coronavirus passes through
July 26, 2020 |  www.proactiveinvestors.com
Circassia Pharmaceuticals Plc
February 16, 2020 |  www.bloomberg.com
See More Headlines


Overall MarketRank

0.89 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 30.25
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CIR News and Ratings via Email

Sign-up to receive the latest news and ratings for CIR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Circassia Group (LON:CIR) Frequently Asked Questions

What stocks does MarketBeat like better than Circassia Group?

Wall Street analysts have given Circassia Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Circassia Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Circassia Group's next earnings date?

Circassia Group is scheduled to release its next quarterly earnings announcement on Monday, June 14th 2021.
View our earnings forecast for Circassia Group

How were Circassia Group's earnings last quarter?

Circassia Group Plc (LON:CIR) issued its quarterly earnings data on Thursday, September, 17th. The company reported ($3.00) earnings per share (EPS) for the quarter.
View Circassia Group's earnings history

How has Circassia Group's stock price been impacted by COVID-19?

Circassia Group's stock was trading at GBX 19.65 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CIR stock has increased by 53.9% and is now trading at GBX 30.25.
View which stocks have been most impacted by COVID-19

Who are Circassia Group's key executives?

Circassia Group's management team includes the following people:
  • Mr. Ian Roy Johnson, Exec. Chairman (Age 67, Pay $160k)
  • Mr. Jonathan Emms, COO & Exec. Director
  • Dr. Roderick Peter Hafner, Sr. VP of R&D (Age 55, Pay $360k)
  • Mr. Michael Roy David Roller A.C.A., BA (Hons), ACA, CFO & Director (Age 56)
  • Ms. Nina Kataria, Sr. VP Global HR
  • Mr. David L. Acheson, Sr. VP of US Commercial
  • Mr. Darren Mercer, Sr. VP of EU & RoW Commercial
  • Sarah Duncan, Company Sec.

Who are some of Circassia Group's key competitors?

What other stocks do shareholders of Circassia Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Circassia Group investors own include EnQuest (ENQ), boohoo group (BHOOY), Cummins (CMI), FutureFuel (FF), The Trade Desk (TTD), Ascential (ASCL), H&T Group (HAT), Howden Joinery Group (HWDN), NMC Health (NMC) and Oxford Biomedica (OXB).

What is Circassia Group's stock symbol?

Circassia Group trades on the London Stock Exchange (LON) under the ticker symbol "CIR."

How do I buy shares of Circassia Group?

Shares of CIR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Circassia Group's stock price today?

One share of CIR stock can currently be purchased for approximately GBX 30.25.

How much money does Circassia Group make?

Circassia Group has a market capitalization of £126.34 million and generates £23.90 million in revenue each year.

How many employees does Circassia Group have?

Circassia Group employs 350 workers across the globe.

What is Circassia Group's official website?

The official website for Circassia Group is www.circassia.co.uk.

How can I contact Circassia Group?

The company can be reached via phone at 44 1865 405 560.

This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.